Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on dev...
Reqorsa Gene Therapy is a Potential Treatment for ALK-EML4 Positive Translocated Non-Small Cell Lung CancerCombining REQORSA wi...
Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on dev...
As of 12:01 a.m. on October 21, 2025, Genprex, Inc., a Delaware corporation (the "Company"), effected the previously di...
